Temporal Transcriptomic Differences in Stroke Between Diabetic and Non-Diabetic Mice
- PMID: 40053254
- DOI: 10.1007/s12031-025-02327-6
Temporal Transcriptomic Differences in Stroke Between Diabetic and Non-Diabetic Mice
Abstract
Diabetes is a key risk factor for ischemic stroke and negatively impacts long-term outcomes post-stroke. However, genomic studies on diabetic stroke remain insufficient. This study aims to investigate the interaction between diabetes and stroke from the acute phase to the early recovery phase by establishing a diabetic stroke animal model and comparing transcriptome sequencing results with those of non-diabetic stroke models. The study identified a greater number of downregulated genes in the diabetic stroke group compared to the non-diabetic group at different stages post-stroke. Functional enrichment analysis revealed an enhanced immune response and a relatively lower neurodegeneration potential in the diabetic group. Post-stroke, a higher presence of CD4 + T cells, eosinophils, and M1 macrophages was observed in the diabetic group. Additionally, time-series analysis identified a set of genes with time-specific expression patterns following diabetic stroke. This study underscores the role of inflammation and immune responses as potential factors exacerbating ischemic stroke in diabetes while also identifying gene regulatory networks at different stages post-stroke. These findings provide new insights into the role of diabetes in stroke and suggest potential therapeutic targets for improving outcomes in diabetic patients.
Keywords: Diabetes mellitus; Inflammatory response; Ischemic stroke; Time-series analysis; Transcriptome.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: All experiments were approved by the Experimental Animal Ethics Committee of the Zhongnan Hospital of Wuhan University. Consent for Publication: All authors have given their consent for publication of this manuscript. Competing Interest: The authors declare no competing interests.
References
-
- Ajjan R, Grant PJ (2006) Coagulation and atherothrombotic disease. Atherosclerosis 186(2):240–259. https://doi.org/10.1016/j.atherosclerosis.2005.10.042 - DOI - PubMed
-
- Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85(2):85–95. https://doi.org/10.1016/s0165-2478(02)00228-6 - DOI - PubMed
-
- Alfieri DF, Lehmann MF, Flauzino T et al (2020) Immune-inflammatory, metabolic, oxidative, and nitrosative stress biomarkers predict acute ischemic stroke and short-term outcome. Neurotox Res 38(2):330–343. https://doi.org/10.1007/s12640-020-00221-0 - DOI - PubMed
-
- Anonymous (2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. The Lancet (British edition) 401;402(10394):2087. https://doi.org/10.1016/S0140-6736(23)01296-5
-
- Arnold R, Kwai N, Lin CS et al (2013) Axonal dysfunction prior to neuropathy onset in type 1 diabetes. Diabetes Metab Res Rev 29(1):53–59. https://doi.org/10.1002/dmrr.2360 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical